These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10559639)

  • 1. Antisense and kidney cell research.
    Ganz MB
    Exp Nephrol; 1999; 7(5-6):413-9. PubMed ID: 10559639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of antisense in kidney cells.
    Ganz MB
    Methods Enzymol; 2000; 314():378-89. PubMed ID: 10565026
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with antisense oligodeoxynucleotides in renal cells.
    Ganz MB; Albrightson C
    Exp Nephrol; 1997; 5(3):175-9. PubMed ID: 9208275
    [No Abstract]   [Full Text] [Related]  

  • 4. Stem cells and kidney diseases.
    Abbattista MR; Schena FP
    Minerva Med; 2004 Oct; 95(5):411-8. PubMed ID: 15467516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of tubular and glomerular cells of the kidney.
    Sorokin L; Ekblom P
    Kidney Int; 1992 Mar; 41(3):657-64. PubMed ID: 1573843
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
    Uchida T; Gao JP; Wang C; Satoh T; Itoh I; Muramoto M; Hyodo T; Irie A; Akahoshi T; Jiang SX; Kameya T; Baba S
    Mol Urol; 2001; 5(2):71-8. PubMed ID: 11690551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The coxsackie and adenovirus receptor (CAR) is required for renal epithelial differentiation within the zebrafish pronephros.
    Raschperger E; Neve EP; Wernerson A; Hultenby K; Pettersson RF; Majumdar A
    Dev Biol; 2008 Jan; 313(1):455-64. PubMed ID: 18062954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue culture in nephrology: potential and limits for the study of renal disease.
    Horster M
    Klin Wochenschr; 1980 Oct; 58(19):965-73. PubMed ID: 7005529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of antisense oligodeoxynucleotides for transplantation.
    Stepkowski SM
    Curr Opin Mol Ther; 2000 Jun; 2(3):304-17. PubMed ID: 11249625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligonucleotides as therapeutic agents.
    Galderisi U; Cascino A; Giordano A
    J Cell Physiol; 1999 Nov; 181(2):251-7. PubMed ID: 10497304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent Advances in Urinalysis as a Diagnostic Indicator of Renal Diseases].
    Yokoyama T; Nitta K
    Rinsho Byori; 2015 Feb; 63(2):252-8. PubMed ID: 26529979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultrastructure of nephrons and kidney tubules].
    Forssmann WG
    Verh Anat Ges; 1972; 67():65-87. PubMed ID: 4670592
    [No Abstract]   [Full Text] [Related]  

  • 13. Low density lipoproteins and mitogenic signal transduction processes: role in the pathogenesis of renal disease.
    Kamanna VS
    Histol Histopathol; 2002 Apr; 17(2):497-505. PubMed ID: 11962755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathways to nephron loss starting from glomerular diseases-insights from animal models.
    Kriz W; LeHir M
    Kidney Int; 2005 Feb; 67(2):404-19. PubMed ID: 15673288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age changes in the human kidney of the different races.
    Tauchi H; Tsuboi K; Okutomi J
    Gerontologia; 1971; 17(2):87-97. PubMed ID: 5093734
    [No Abstract]   [Full Text] [Related]  

  • 16. A scanning electron microscopic study of the nephron.
    Andrews PM; Porter KR
    Am J Anat; 1974 May; 140(1):81-115. PubMed ID: 4132935
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasticity of kidney cells: role in kidney remodeling and scarring.
    El-Nahas AM
    Kidney Int; 2003 Nov; 64(5):1553-63. PubMed ID: 14531787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms in remodeling of the kidney].
    Nangaku M; Miyata T
    Nihon Rinsho; 2008 Sep; 66(9):1696-700. PubMed ID: 18788396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of antisense technology to urologic cancers.
    Tomita Y
    Mol Urol; 2000; 4(2):55-9. PubMed ID: 12006243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoy oligodeoxynucleotides as novel cardiovascular drugs for cardiovascular disease.
    Morishita R; Aoki M; Kaneda Y
    Ann N Y Acad Sci; 2001 Dec; 947():294-301; discussion 301-2. PubMed ID: 11795277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.